nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—CYP2C8—Sulfadiazine—malaria	0.0654	0.0912	CbGbCtD
Meloxicam—CYP2C8—Pyrimethamine—malaria	0.0654	0.0912	CbGbCtD
Meloxicam—PTGS2—Dapsone—malaria	0.0524	0.0731	CbGbCtD
Meloxicam—CYP3A4—Clindamycin—malaria	0.0462	0.0644	CbGbCtD
Meloxicam—CYP2C9—Sulfadiazine—malaria	0.0456	0.0636	CbGbCtD
Meloxicam—CYP2C9—Pyrimethamine—malaria	0.0456	0.0636	CbGbCtD
Meloxicam—PTGS1—Dapsone—malaria	0.0442	0.0617	CbGbCtD
Meloxicam—CYP2C9—Artemether—malaria	0.0388	0.0541	CbGbCtD
Meloxicam—CYP2C9—Proguanil—malaria	0.0365	0.0508	CbGbCtD
Meloxicam—CYP2C8—Quinine—malaria	0.0337	0.047	CbGbCtD
Meloxicam—CYP2C8—Quinidine—malaria	0.0296	0.0413	CbGbCtD
Meloxicam—CYP3A4—Sulfadiazine—malaria	0.0265	0.037	CbGbCtD
Meloxicam—CYP2C8—Dapsone—malaria	0.0255	0.0356	CbGbCtD
Meloxicam—CYP2C9—Quinine—malaria	0.0235	0.0328	CbGbCtD
Meloxicam—CYP3A4—Artemether—malaria	0.0226	0.0314	CbGbCtD
Meloxicam—CYP3A4—Proguanil—malaria	0.0212	0.0296	CbGbCtD
Meloxicam—CYP2C9—Quinidine—malaria	0.0207	0.0288	CbGbCtD
Meloxicam—CYP3A4—Doxycycline—malaria	0.0201	0.028	CbGbCtD
Meloxicam—CYP2C9—Dapsone—malaria	0.0178	0.0248	CbGbCtD
Meloxicam—CYP3A4—Quinine—malaria	0.0137	0.0191	CbGbCtD
Meloxicam—CYP3A4—Quinidine—malaria	0.012	0.0167	CbGbCtD
Meloxicam—CYP3A4—Dapsone—malaria	0.0104	0.0144	CbGbCtD
Meloxicam—PGD—Pentose Phosphate Pathway—G6PD—malaria	0.0095	0.324	CbGpPWpGaD
Meloxicam—PGD—blood plasma—malaria	0.00432	0.0707	CbGeAlD
Meloxicam—ABCC4—blood plasma—malaria	0.00307	0.0503	CbGeAlD
Meloxicam—PGD—saliva-secreting gland—malaria	0.0025	0.041	CbGeAlD
Meloxicam—PGD—hematopoietic system—malaria	0.00239	0.0391	CbGeAlD
Meloxicam—CYP2C8—blood plasma—malaria	0.00223	0.0365	CbGeAlD
Meloxicam—PTGS1—endothelium—malaria	0.00204	0.0333	CbGeAlD
Meloxicam—CYP2C9—blood plasma—malaria	0.00198	0.0324	CbGeAlD
Meloxicam—PGD—kidney—malaria	0.00196	0.032	CbGeAlD
Meloxicam—PTGS2—endothelium—malaria	0.00195	0.0319	CbGeAlD
Meloxicam—PTGS1—blood plasma—malaria	0.00181	0.0296	CbGeAlD
Meloxicam—PTGS2—blood plasma—malaria	0.00173	0.0283	CbGeAlD
Meloxicam—ABCC4—hematopoietic system—malaria	0.0017	0.0278	CbGeAlD
Meloxicam—PGD—digestive system—malaria	0.00166	0.0272	CbGeAlD
Meloxicam—PGD—blood—malaria	0.00158	0.0259	CbGeAlD
Meloxicam—PGD—bone marrow—malaria	0.00153	0.0251	CbGeAlD
Meloxicam—CYP3A4—blood plasma—malaria	0.00151	0.0247	CbGeAlD
Meloxicam—ABCC4—kidney—malaria	0.00139	0.0228	CbGeAlD
Meloxicam—PGD—liver—malaria	0.00124	0.0202	CbGeAlD
Meloxicam—CYP2C8—hematopoietic system—malaria	0.00123	0.0202	CbGeAlD
Meloxicam—ABCC4—digestive system—malaria	0.00118	0.0193	CbGeAlD
Meloxicam—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00117	0.0398	CbGpPWpGaD
Meloxicam—ABCC4—blood—malaria	0.00113	0.0184	CbGeAlD
Meloxicam—CYP2C9—hematopoietic system—malaria	0.0011	0.0179	CbGeAlD
Meloxicam—ABCC4—bone marrow—malaria	0.00109	0.0178	CbGeAlD
Meloxicam—CYP2C8—kidney—malaria	0.00101	0.0165	CbGeAlD
Meloxicam—PTGS1—hematopoietic system—malaria	0.001	0.0164	CbGeAlD
Meloxicam—PGD—brain—malaria	0.000983	0.0161	CbGeAlD
Meloxicam—PTGS2—hematopoietic system—malaria	0.000957	0.0156	CbGeAlD
Meloxicam—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.000927	0.0316	CbGpPWpGaD
Meloxicam—ABCC4—liver—malaria	0.000881	0.0144	CbGeAlD
Meloxicam—PGD—NRF2 pathway—G6PD—malaria	0.000837	0.0285	CbGpPWpGaD
Meloxicam—CYP3A4—hematopoietic system—malaria	0.000836	0.0137	CbGeAlD
Meloxicam—PTGS1—kidney—malaria	0.00082	0.0134	CbGeAlD
Meloxicam—CYP2C8—blood—malaria	0.000818	0.0134	CbGeAlD
Meloxicam—PTGS2—kidney—malaria	0.000784	0.0128	CbGeAlD
Meloxicam—ABCC4—Fluoropyrimidine Activity—DHFR—malaria	0.000774	0.0264	CbGpPWpGaD
Meloxicam—CYP2C9—digestive system—malaria	0.000762	0.0125	CbGeAlD
Meloxicam—CYP2C9—blood—malaria	0.000726	0.0119	CbGeAlD
Meloxicam—ABCC4—brain—malaria	0.000699	0.0114	CbGeAlD
Meloxicam—PTGS1—digestive system—malaria	0.000696	0.0114	CbGeAlD
Meloxicam—CYP3A4—kidney—malaria	0.000685	0.0112	CbGeAlD
Meloxicam—PTGS2—digestive system—malaria	0.000665	0.0109	CbGeAlD
Meloxicam—PTGS1—blood—malaria	0.000663	0.0108	CbGeAlD
Meloxicam—CYP2C8—liver—malaria	0.000639	0.0105	CbGeAlD
Meloxicam—PTGS2—blood—malaria	0.000634	0.0104	CbGeAlD
Meloxicam—PTGS2—bone marrow—malaria	0.000613	0.01	CbGeAlD
Meloxicam—PGD—Carbohydrate metabolism—PKLR—malaria	0.000593	0.0202	CbGpPWpGaD
Meloxicam—CYP3A4—digestive system—malaria	0.000581	0.00951	CbGeAlD
Meloxicam—CYP2C9—liver—malaria	0.000568	0.00929	CbGeAlD
Meloxicam—CYP3A4—blood—malaria	0.000554	0.00906	CbGeAlD
Meloxicam—PGD—Carbohydrate metabolism—G6PD—malaria	0.000529	0.018	CbGpPWpGaD
Meloxicam—CYP2C8—brain—malaria	0.000507	0.0083	CbGeAlD
Meloxicam—PTGS2—liver—malaria	0.000496	0.0081	CbGeAlD
Meloxicam—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000475	0.0162	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.000443	0.0151	CbGpPWpGaD
Meloxicam—CYP3A4—liver—malaria	0.000433	0.00708	CbGeAlD
Meloxicam—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000422	0.0144	CbGpPWpGaD
Meloxicam—PTGS1—brain—malaria	0.000411	0.00673	CbGeAlD
Meloxicam—PTGS2—brain—malaria	0.000393	0.00643	CbGeAlD
Meloxicam—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000377	0.0129	CbGpPWpGaD
Meloxicam—PTGS2—S1P1 pathway—KDR—malaria	0.000362	0.0123	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000358	0.0122	CbGpPWpGaD
Meloxicam—Malnutrition—Quinidine—malaria	0.000352	0.00183	CcSEcCtD
Meloxicam—Nausea—Proguanil—malaria	0.000352	0.00183	CcSEcCtD
Meloxicam—Visual impairment—Quinidine barbiturate—malaria	0.000352	0.00183	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000352	0.012	CbGpPWpGaD
Meloxicam—Dysgeusia—Clindamycin—malaria	0.000351	0.00183	CcSEcCtD
Meloxicam—Vision blurred—Dapsone—malaria	0.000349	0.00182	CcSEcCtD
Meloxicam—Back pain—Clindamycin—malaria	0.000347	0.0018	CcSEcCtD
Meloxicam—Erythema multiforme—Quinidine barbiturate—malaria	0.000345	0.00179	CcSEcCtD
Meloxicam—Muscle spasms—Clindamycin—malaria	0.000345	0.00179	CcSEcCtD
Meloxicam—Decreased appetite—Sulfadiazine—malaria	0.000342	0.00178	CcSEcCtD
Meloxicam—Eye disorder—Quinidine barbiturate—malaria	0.000341	0.00177	CcSEcCtD
Meloxicam—Tinnitus—Quinidine barbiturate—malaria	0.00034	0.00177	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Sulfadiazine—malaria	0.000339	0.00177	CcSEcCtD
Meloxicam—Flushing—Quinidine barbiturate—malaria	0.000339	0.00176	CcSEcCtD
Meloxicam—Cardiac disorder—Quinidine barbiturate—malaria	0.000339	0.00176	CcSEcCtD
Meloxicam—Flushing—Pentoxifylline—malaria	0.000338	0.00176	CcSEcCtD
Meloxicam—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000335	0.0114	CbGpPWpGaD
Meloxicam—Vertigo—Dapsone—malaria	0.000333	0.00173	CcSEcCtD
Meloxicam—ABCC4—NRF2 pathway—G6PD—malaria	0.000333	0.0114	CbGpPWpGaD
Meloxicam—Vision blurred—Quinidine—malaria	0.000332	0.00172	CcSEcCtD
Meloxicam—Vision blurred—Quinine—malaria	0.000332	0.00172	CcSEcCtD
Meloxicam—Anaemia—Clindamycin—malaria	0.000332	0.00172	CcSEcCtD
Meloxicam—Tremor—Quinine—malaria	0.00033	0.00171	CcSEcCtD
Meloxicam—Tremor—Quinidine—malaria	0.00033	0.00171	CcSEcCtD
Meloxicam—Immune system disorder—Quinidine barbiturate—malaria	0.00033	0.00171	CcSEcCtD
Meloxicam—Immune system disorder—Pentoxifylline—malaria	0.000329	0.00171	CcSEcCtD
Meloxicam—Mediastinal disorder—Quinidine barbiturate—malaria	0.000329	0.00171	CcSEcCtD
Meloxicam—Arrhythmia—Pentoxifylline—malaria	0.000325	0.00169	CcSEcCtD
Meloxicam—Cough—Dapsone—malaria	0.000324	0.00168	CcSEcCtD
Meloxicam—Vertigo—Clindamycin—malaria	0.000322	0.00168	CcSEcCtD
Meloxicam—Angioedema—Quinine—malaria	0.000322	0.00167	CcSEcCtD
Meloxicam—Angioedema—Quinidine—malaria	0.000322	0.00167	CcSEcCtD
Meloxicam—Gastrointestinal pain—Sulfadiazine—malaria	0.000321	0.00167	CcSEcCtD
Meloxicam—Leukopenia—Clindamycin—malaria	0.000321	0.00167	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.00032	0.0109	CbGpPWpGaD
Meloxicam—Mental disorder—Quinidine barbiturate—malaria	0.00032	0.00166	CcSEcCtD
Meloxicam—Erythema—Quinidine barbiturate—malaria	0.000318	0.00165	CcSEcCtD
Meloxicam—Malnutrition—Quinidine barbiturate—malaria	0.000318	0.00165	CcSEcCtD
Meloxicam—Erythema—Pentoxifylline—malaria	0.000317	0.00165	CcSEcCtD
Meloxicam—Vertigo—Quinine—malaria	0.000316	0.00164	CcSEcCtD
Meloxicam—Vertigo—Quinidine—malaria	0.000316	0.00164	CcSEcCtD
Meloxicam—Syncope—Quinidine—malaria	0.000316	0.00164	CcSEcCtD
Meloxicam—Syncope—Quinine—malaria	0.000316	0.00164	CcSEcCtD
Meloxicam—Leukopenia—Quinine—malaria	0.000315	0.00164	CcSEcCtD
Meloxicam—Leukopenia—Quinidine—malaria	0.000315	0.00164	CcSEcCtD
Meloxicam—Flatulence—Pentoxifylline—malaria	0.000312	0.00162	CcSEcCtD
Meloxicam—Urticaria—Sulfadiazine—malaria	0.000312	0.00162	CcSEcCtD
Meloxicam—Tension—Quinidine barbiturate—malaria	0.000312	0.00162	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.000311	0.0106	CbGpPWpGaD
Meloxicam—Tension—Pentoxifylline—malaria	0.000311	0.00162	CcSEcCtD
Meloxicam—Palpitations—Quinidine—malaria	0.000311	0.00162	CcSEcCtD
Meloxicam—Palpitations—Quinine—malaria	0.000311	0.00162	CcSEcCtD
Meloxicam—Body temperature increased—Sulfadiazine—malaria	0.000311	0.00162	CcSEcCtD
Meloxicam—Abdominal pain—Sulfadiazine—malaria	0.000311	0.00162	CcSEcCtD
Meloxicam—Dysgeusia—Pentoxifylline—malaria	0.00031	0.00161	CcSEcCtD
Meloxicam—Hypertension—Clindamycin—malaria	0.00031	0.00161	CcSEcCtD
Meloxicam—Loss of consciousness—Quinidine—malaria	0.000309	0.00161	CcSEcCtD
Meloxicam—Loss of consciousness—Quinine—malaria	0.000309	0.00161	CcSEcCtD
Meloxicam—Nervousness—Quinidine barbiturate—malaria	0.000308	0.0016	CcSEcCtD
Meloxicam—Nervousness—Pentoxifylline—malaria	0.000308	0.0016	CcSEcCtD
Meloxicam—Back pain—Pentoxifylline—malaria	0.000307	0.00159	CcSEcCtD
Meloxicam—Convulsion—Quinine—malaria	0.000305	0.00159	CcSEcCtD
Meloxicam—Convulsion—Quinidine—malaria	0.000305	0.00159	CcSEcCtD
Meloxicam—Muscle spasms—Pentoxifylline—malaria	0.000305	0.00159	CcSEcCtD
Meloxicam—Discomfort—Clindamycin—malaria	0.000302	0.00157	CcSEcCtD
Meloxicam—Myalgia—Quinidine—malaria	0.0003	0.00156	CcSEcCtD
Meloxicam—Myalgia—Quinine—malaria	0.0003	0.00156	CcSEcCtD
Meloxicam—Vision blurred—Quinidine barbiturate—malaria	0.000299	0.00156	CcSEcCtD
Meloxicam—Vision blurred—Pentoxifylline—malaria	0.000299	0.00155	CcSEcCtD
Meloxicam—Tremor—Quinidine barbiturate—malaria	0.000298	0.00155	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000298	0.00155	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000298	0.00155	CcSEcCtD
Meloxicam—Tremor—Pentoxifylline—malaria	0.000297	0.00154	CcSEcCtD
Meloxicam—Tachycardia—Dapsone—malaria	0.000295	0.00154	CcSEcCtD
Meloxicam—Ill-defined disorder—Pentoxifylline—malaria	0.000294	0.00153	CcSEcCtD
Meloxicam—Anaemia—Pentoxifylline—malaria	0.000293	0.00152	CcSEcCtD
Meloxicam—Anaphylactic shock—Clindamycin—malaria	0.000293	0.00152	CcSEcCtD
Meloxicam—Angioedema—Quinidine barbiturate—malaria	0.00029	0.00151	CcSEcCtD
Meloxicam—Angioedema—Pentoxifylline—malaria	0.00029	0.00151	CcSEcCtD
Meloxicam—Hypersensitivity—Sulfadiazine—malaria	0.00029	0.00151	CcSEcCtD
Meloxicam—Confusional state—Quinine—malaria	0.00029	0.00151	CcSEcCtD
Meloxicam—Confusional state—Quinidine—malaria	0.00029	0.00151	CcSEcCtD
Meloxicam—Oedema—Quinine—malaria	0.000287	0.00149	CcSEcCtD
Meloxicam—Oedema—Quinidine—malaria	0.000287	0.00149	CcSEcCtD
Meloxicam—Thrombocytopenia—Clindamycin—malaria	0.000287	0.00149	CcSEcCtD
Meloxicam—Malaise—Pentoxifylline—malaria	0.000286	0.00149	CcSEcCtD
Meloxicam—Vertigo—Quinidine barbiturate—malaria	0.000285	0.00148	CcSEcCtD
Meloxicam—Syncope—Quinidine barbiturate—malaria	0.000285	0.00148	CcSEcCtD
Meloxicam—Leukopenia—Quinidine barbiturate—malaria	0.000284	0.00148	CcSEcCtD
Meloxicam—Leukopenia—Pentoxifylline—malaria	0.000284	0.00148	CcSEcCtD
Meloxicam—Shock—Quinidine—malaria	0.000283	0.00147	CcSEcCtD
Meloxicam—Shock—Quinine—malaria	0.000283	0.00147	CcSEcCtD
Meloxicam—Nervous system disorder—Quinidine—malaria	0.000282	0.00146	CcSEcCtD
Meloxicam—Nervous system disorder—Quinine—malaria	0.000282	0.00146	CcSEcCtD
Meloxicam—Thrombocytopenia—Quinidine—malaria	0.000281	0.00146	CcSEcCtD
Meloxicam—Thrombocytopenia—Quinine—malaria	0.000281	0.00146	CcSEcCtD
Meloxicam—Palpitations—Quinidine barbiturate—malaria	0.000281	0.00146	CcSEcCtD
Meloxicam—Tachycardia—Quinidine—malaria	0.00028	0.00146	CcSEcCtD
Meloxicam—Tachycardia—Quinine—malaria	0.00028	0.00146	CcSEcCtD
Meloxicam—Palpitations—Pentoxifylline—malaria	0.00028	0.00146	CcSEcCtD
Meloxicam—Loss of consciousness—Quinidine barbiturate—malaria	0.000279	0.00145	CcSEcCtD
Meloxicam—Skin disorder—Quinine—malaria	0.000279	0.00145	CcSEcCtD
Meloxicam—Skin disorder—Quinidine—malaria	0.000279	0.00145	CcSEcCtD
Meloxicam—Pruritus—Sulfadiazine—malaria	0.000278	0.00145	CcSEcCtD
Meloxicam—Hyperhidrosis—Quinine—malaria	0.000278	0.00144	CcSEcCtD
Meloxicam—Hyperhidrosis—Quinidine—malaria	0.000278	0.00144	CcSEcCtD
Meloxicam—Convulsion—Quinidine barbiturate—malaria	0.000275	0.00143	CcSEcCtD
Meloxicam—Convulsion—Pentoxifylline—malaria	0.000275	0.00143	CcSEcCtD
Meloxicam—Insomnia—Dapsone—malaria	0.000274	0.00142	CcSEcCtD
Meloxicam—Hypertension—Pentoxifylline—malaria	0.000274	0.00142	CcSEcCtD
Meloxicam—Hypotension—Clindamycin—malaria	0.000274	0.00142	CcSEcCtD
Meloxicam—CYP2C8—Arachidonic acid metabolism—HPGDS—malaria	0.000272	0.00928	CbGpPWpGaD
Meloxicam—Arthralgia—Quinidine barbiturate—malaria	0.00027	0.00141	CcSEcCtD
Meloxicam—Myalgia—Quinidine barbiturate—malaria	0.00027	0.00141	CcSEcCtD
Meloxicam—Myalgia—Pentoxifylline—malaria	0.00027	0.0014	CcSEcCtD
Meloxicam—Anxiety—Quinidine barbiturate—malaria	0.000269	0.0014	CcSEcCtD
Meloxicam—Diarrhoea—Sulfadiazine—malaria	0.000269	0.0014	CcSEcCtD
Meloxicam—Anxiety—Pentoxifylline—malaria	0.000269	0.0014	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000269	0.0014	CcSEcCtD
Meloxicam—Hypotension—Quinidine—malaria	0.000268	0.0014	CcSEcCtD
Meloxicam—Hypotension—Quinine—malaria	0.000268	0.0014	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000268	0.00139	CcSEcCtD
Meloxicam—Discomfort—Pentoxifylline—malaria	0.000267	0.00139	CcSEcCtD
Meloxicam—Dry mouth—Pentoxifylline—malaria	0.000264	0.00137	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Quinine—malaria	0.000262	0.00136	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Quinidine—malaria	0.000262	0.00136	CcSEcCtD
Meloxicam—Confusional state—Quinidine barbiturate—malaria	0.000261	0.00136	CcSEcCtD
Meloxicam—Dyspnoea—Clindamycin—malaria	0.000261	0.00136	CcSEcCtD
Meloxicam—Confusional state—Pentoxifylline—malaria	0.000261	0.00136	CcSEcCtD
Meloxicam—Oedema—Quinidine barbiturate—malaria	0.000259	0.00135	CcSEcCtD
Meloxicam—Anaphylactic shock—Pentoxifylline—malaria	0.000259	0.00135	CcSEcCtD
Meloxicam—Oedema—Pentoxifylline—malaria	0.000259	0.00135	CcSEcCtD
Meloxicam—Dyspepsia—Clindamycin—malaria	0.000258	0.00134	CcSEcCtD
Meloxicam—Infection—Pentoxifylline—malaria	0.000257	0.00134	CcSEcCtD
Meloxicam—Dyspnoea—Quinine—malaria	0.000256	0.00133	CcSEcCtD
Meloxicam—Dyspnoea—Quinidine—malaria	0.000256	0.00133	CcSEcCtD
Meloxicam—Shock—Quinidine barbiturate—malaria	0.000255	0.00133	CcSEcCtD
Meloxicam—Shock—Pentoxifylline—malaria	0.000255	0.00132	CcSEcCtD
Meloxicam—Nervous system disorder—Quinidine barbiturate—malaria	0.000254	0.00132	CcSEcCtD
Meloxicam—Thrombocytopenia—Quinidine barbiturate—malaria	0.000254	0.00132	CcSEcCtD
Meloxicam—Thrombocytopenia—Pentoxifylline—malaria	0.000253	0.00132	CcSEcCtD
Meloxicam—Tachycardia—Quinidine barbiturate—malaria	0.000253	0.00132	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Clindamycin—malaria	0.000253	0.00131	CcSEcCtD
Meloxicam—Tachycardia—Pentoxifylline—malaria	0.000253	0.00131	CcSEcCtD
Meloxicam—Fatigue—Clindamycin—malaria	0.000252	0.00131	CcSEcCtD
Meloxicam—Skin disorder—Quinidine barbiturate—malaria	0.000252	0.00131	CcSEcCtD
Meloxicam—Skin disorder—Pentoxifylline—malaria	0.000251	0.00131	CcSEcCtD
Meloxicam—Hyperhidrosis—Quinidine barbiturate—malaria	0.000251	0.0013	CcSEcCtD
Meloxicam—Pain—Clindamycin—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Constipation—Clindamycin—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Hyperhidrosis—Pentoxifylline—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Vomiting—Sulfadiazine—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Decreased appetite—Quinine—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Decreased appetite—Quinidine—malaria	0.00025	0.0013	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Quinidine—malaria	0.000248	0.00129	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Quinine—malaria	0.000248	0.00129	CcSEcCtD
Meloxicam—Rash—Sulfadiazine—malaria	0.000248	0.00129	CcSEcCtD
Meloxicam—Dermatitis—Sulfadiazine—malaria	0.000248	0.00129	CcSEcCtD
Meloxicam—Gastrointestinal pain—Dapsone—malaria	0.000247	0.00129	CcSEcCtD
Meloxicam—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000246	0.0084	CbGpPWpGaD
Meloxicam—Headache—Sulfadiazine—malaria	0.000246	0.00128	CcSEcCtD
Meloxicam—Hypotension—Quinidine barbiturate—malaria	0.000242	0.00126	CcSEcCtD
Meloxicam—Hypotension—Pentoxifylline—malaria	0.000242	0.00126	CcSEcCtD
Meloxicam—Gastrointestinal pain—Clindamycin—malaria	0.000239	0.00125	CcSEcCtD
Meloxicam—Abdominal pain—Dapsone—malaria	0.000239	0.00124	CcSEcCtD
Meloxicam—Body temperature increased—Dapsone—malaria	0.000239	0.00124	CcSEcCtD
Meloxicam—ABCC4—Platelet degranulation—CD36—malaria	0.000237	0.00807	CbGpPWpGaD
Meloxicam—Feeling abnormal—Quinine—malaria	0.000237	0.00123	CcSEcCtD
Meloxicam—Feeling abnormal—Quinidine—malaria	0.000237	0.00123	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000236	0.00123	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000236	0.00123	CcSEcCtD
Meloxicam—Gastrointestinal pain—Quinine—malaria	0.000235	0.00122	CcSEcCtD
Meloxicam—Gastrointestinal pain—Quinidine—malaria	0.000235	0.00122	CcSEcCtD
Meloxicam—Insomnia—Pentoxifylline—malaria	0.000234	0.00122	CcSEcCtD
Meloxicam—Nausea—Sulfadiazine—malaria	0.000234	0.00121	CcSEcCtD
Meloxicam—Urticaria—Clindamycin—malaria	0.000233	0.00121	CcSEcCtD
Meloxicam—Body temperature increased—Clindamycin—malaria	0.000231	0.0012	CcSEcCtD
Meloxicam—Abdominal pain—Clindamycin—malaria	0.000231	0.0012	CcSEcCtD
Meloxicam—Dyspnoea—Quinidine barbiturate—malaria	0.000231	0.0012	CcSEcCtD
Meloxicam—Dyspnoea—Pentoxifylline—malaria	0.000231	0.0012	CcSEcCtD
Meloxicam—Somnolence—Quinidine barbiturate—malaria	0.00023	0.0012	CcSEcCtD
Meloxicam—Somnolence—Pentoxifylline—malaria	0.00023	0.0012	CcSEcCtD
Meloxicam—Urticaria—Quinidine—malaria	0.000228	0.00119	CcSEcCtD
Meloxicam—Urticaria—Quinine—malaria	0.000228	0.00119	CcSEcCtD
Meloxicam—Dyspepsia—Pentoxifylline—malaria	0.000228	0.00118	CcSEcCtD
Meloxicam—Abdominal pain—Quinine—malaria	0.000227	0.00118	CcSEcCtD
Meloxicam—Abdominal pain—Quinidine—malaria	0.000227	0.00118	CcSEcCtD
Meloxicam—Body temperature increased—Quinidine—malaria	0.000227	0.00118	CcSEcCtD
Meloxicam—Body temperature increased—Quinine—malaria	0.000227	0.00118	CcSEcCtD
Meloxicam—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—malaria	0.000226	0.00769	CbGpPWpGaD
Meloxicam—Decreased appetite—Quinidine barbiturate—malaria	0.000225	0.00117	CcSEcCtD
Meloxicam—Decreased appetite—Pentoxifylline—malaria	0.000225	0.00117	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000224	0.00116	CcSEcCtD
Meloxicam—CYP2C9—Arachidonic acid metabolism—HPGDS—malaria	0.000222	0.00756	CbGpPWpGaD
Meloxicam—Constipation—Quinidine barbiturate—malaria	0.000222	0.00115	CcSEcCtD
Meloxicam—Pain—Quinidine barbiturate—malaria	0.000222	0.00115	CcSEcCtD
Meloxicam—Constipation—Pentoxifylline—malaria	0.000221	0.00115	CcSEcCtD
Meloxicam—PGD—Metabolism—DHODH—malaria	0.000218	0.00745	CbGpPWpGaD
Meloxicam—Hypersensitivity—Clindamycin—malaria	0.000216	0.00112	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000215	0.00733	CbGpPWpGaD
Meloxicam—Feeling abnormal—Quinidine barbiturate—malaria	0.000214	0.00111	CcSEcCtD
Meloxicam—Feeling abnormal—Pentoxifylline—malaria	0.000213	0.00111	CcSEcCtD
Meloxicam—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000212	0.0011	CcSEcCtD
Meloxicam—Hypersensitivity—Quinidine—malaria	0.000212	0.0011	CcSEcCtD
Meloxicam—Hypersensitivity—Quinine—malaria	0.000212	0.0011	CcSEcCtD
Meloxicam—Gastrointestinal pain—Pentoxifylline—malaria	0.000212	0.0011	CcSEcCtD
Meloxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000211	0.00719	CbGpPWpGaD
Meloxicam—Asthenia—Clindamycin—malaria	0.00021	0.00109	CcSEcCtD
Meloxicam—Pruritus—Clindamycin—malaria	0.000207	0.00108	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000207	0.00705	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000206	0.00703	CbGpPWpGaD
Meloxicam—Asthenia—Quinine—malaria	0.000206	0.00107	CcSEcCtD
Meloxicam—Asthenia—Quinidine—malaria	0.000206	0.00107	CcSEcCtD
Meloxicam—Urticaria—Quinidine barbiturate—malaria	0.000206	0.00107	CcSEcCtD
Meloxicam—Urticaria—Pentoxifylline—malaria	0.000206	0.00107	CcSEcCtD
Meloxicam—Body temperature increased—Quinidine barbiturate—malaria	0.000205	0.00107	CcSEcCtD
Meloxicam—Abdominal pain—Quinidine barbiturate—malaria	0.000205	0.00107	CcSEcCtD
Meloxicam—Body temperature increased—Pentoxifylline—malaria	0.000205	0.00106	CcSEcCtD
Meloxicam—Abdominal pain—Pentoxifylline—malaria	0.000205	0.00106	CcSEcCtD
Meloxicam—Pruritus—Quinidine—malaria	0.000203	0.00106	CcSEcCtD
Meloxicam—Pruritus—Quinine—malaria	0.000203	0.00106	CcSEcCtD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000201	0.00686	CbGpPWpGaD
Meloxicam—Diarrhoea—Clindamycin—malaria	0.0002	0.00104	CcSEcCtD
Meloxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000199	0.0068	CbGpPWpGaD
Meloxicam—Diarrhoea—Quinidine—malaria	0.000197	0.00102	CcSEcCtD
Meloxicam—Diarrhoea—Quinine—malaria	0.000197	0.00102	CcSEcCtD
Meloxicam—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000196	0.00667	CbGpPWpGaD
Meloxicam—Dizziness—Clindamycin—malaria	0.000194	0.00101	CcSEcCtD
Meloxicam—Vomiting—Dapsone—malaria	0.000192	0.001	CcSEcCtD
Meloxicam—Hypersensitivity—Quinidine barbiturate—malaria	0.000191	0.000993	CcSEcCtD
Meloxicam—Hypersensitivity—Pentoxifylline—malaria	0.000191	0.000991	CcSEcCtD
Meloxicam—Dizziness—Quinine—malaria	0.00019	0.000988	CcSEcCtD
Meloxicam—Dizziness—Quinidine—malaria	0.00019	0.000988	CcSEcCtD
Meloxicam—Headache—Dapsone—malaria	0.00019	0.000986	CcSEcCtD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000188	0.00641	CbGpPWpGaD
Meloxicam—Vomiting—Clindamycin—malaria	0.000186	0.000968	CcSEcCtD
Meloxicam—Asthenia—Quinidine barbiturate—malaria	0.000186	0.000967	CcSEcCtD
Meloxicam—PGD—Metabolism—SLC4A1—malaria	0.000186	0.00633	CbGpPWpGaD
Meloxicam—Asthenia—Pentoxifylline—malaria	0.000186	0.000965	CcSEcCtD
Meloxicam—Rash—Clindamycin—malaria	0.000185	0.00096	CcSEcCtD
Meloxicam—Dermatitis—Clindamycin—malaria	0.000184	0.000959	CcSEcCtD
Meloxicam—Headache—Clindamycin—malaria	0.000183	0.000954	CcSEcCtD
Meloxicam—Pruritus—Quinidine barbiturate—malaria	0.000183	0.000954	CcSEcCtD
Meloxicam—Pruritus—Pentoxifylline—malaria	0.000183	0.000952	CcSEcCtD
Meloxicam—Vomiting—Quinidine—malaria	0.000183	0.00095	CcSEcCtD
Meloxicam—Vomiting—Quinine—malaria	0.000183	0.00095	CcSEcCtD
Meloxicam—Rash—Quinine—malaria	0.000181	0.000942	CcSEcCtD
Meloxicam—Rash—Quinidine—malaria	0.000181	0.000942	CcSEcCtD
Meloxicam—Dermatitis—Quinidine—malaria	0.000181	0.000941	CcSEcCtD
Meloxicam—Dermatitis—Quinine—malaria	0.000181	0.000941	CcSEcCtD
Meloxicam—Headache—Quinine—malaria	0.00018	0.000936	CcSEcCtD
Meloxicam—Headache—Quinidine—malaria	0.00018	0.000936	CcSEcCtD
Meloxicam—Nausea—Dapsone—malaria	0.00018	0.000935	CcSEcCtD
Meloxicam—Diarrhoea—Quinidine barbiturate—malaria	0.000177	0.000922	CcSEcCtD
Meloxicam—Diarrhoea—Pentoxifylline—malaria	0.000177	0.000921	CcSEcCtD
Meloxicam—PGD—Metabolism—DECR1—malaria	0.000175	0.00595	CbGpPWpGaD
Meloxicam—Nausea—Clindamycin—malaria	0.000174	0.000904	CcSEcCtD
Meloxicam—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000174	0.00591	CbGpPWpGaD
Meloxicam—Dizziness—Quinidine barbiturate—malaria	0.000171	0.000891	CcSEcCtD
Meloxicam—Dizziness—Pentoxifylline—malaria	0.000171	0.00089	CcSEcCtD
Meloxicam—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000171	0.00582	CbGpPWpGaD
Meloxicam—Nausea—Quinidine—malaria	0.000171	0.000887	CcSEcCtD
Meloxicam—Nausea—Quinine—malaria	0.000171	0.000887	CcSEcCtD
Meloxicam—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000168	0.00574	CbGpPWpGaD
Meloxicam—PGD—Disease—PKLR—malaria	0.000168	0.00573	CbGpPWpGaD
Meloxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000167	0.0057	CbGpPWpGaD
Meloxicam—Vomiting—Quinidine barbiturate—malaria	0.000165	0.000857	CcSEcCtD
Meloxicam—Vomiting—Pentoxifylline—malaria	0.000165	0.000856	CcSEcCtD
Meloxicam—Rash—Quinidine barbiturate—malaria	0.000163	0.00085	CcSEcCtD
Meloxicam—Dermatitis—Quinidine barbiturate—malaria	0.000163	0.000849	CcSEcCtD
Meloxicam—Rash—Pentoxifylline—malaria	0.000163	0.000848	CcSEcCtD
Meloxicam—Dermatitis—Pentoxifylline—malaria	0.000163	0.000848	CcSEcCtD
Meloxicam—Headache—Quinidine barbiturate—malaria	0.000162	0.000844	CcSEcCtD
Meloxicam—Headache—Pentoxifylline—malaria	0.000162	0.000843	CcSEcCtD
Meloxicam—PGD—Metabolism—HBB—malaria	0.000158	0.00538	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—SLC4A1—malaria	0.000158	0.00538	CbGpPWpGaD
Meloxicam—PTGS1—Biological oxidations—HPGDS—malaria	0.000157	0.00535	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—HBB—malaria	0.000155	0.00529	CbGpPWpGaD
Meloxicam—Nausea—Quinidine barbiturate—malaria	0.000154	0.000801	CcSEcCtD
Meloxicam—Nausea—Pentoxifylline—malaria	0.000154	0.000799	CcSEcCtD
Meloxicam—PGD—Disease—G6PD—malaria	0.00015	0.00511	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PKLR—malaria	0.000141	0.0048	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.000139	0.00475	CbGpPWpGaD
Meloxicam—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000138	0.0047	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000128	0.00437	CbGpPWpGaD
Meloxicam—PGD—Metabolism—G6PD—malaria	0.000125	0.00428	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000122	0.00415	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000115	0.00391	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000111	0.00377	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.00011	0.00375	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000108	0.00368	CbGpPWpGaD
Meloxicam—PGD—Disease—DHFR—malaria	0.000106	0.00361	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—CD36—malaria	0.000105	0.00358	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000102	0.00347	CbGpPWpGaD
Meloxicam—CYP2C8—Biological oxidations—HPGDS—malaria	0.000101	0.00346	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL4—malaria	0.000101	0.00345	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IFNG—malaria	9.75e-05	0.00332	CbGpPWpGaD
Meloxicam—PGD—Metabolism—HPGDS—malaria	9.57e-05	0.00326	CbGpPWpGaD
Meloxicam—PGD—Metabolism—DHFR—malaria	8.88e-05	0.00303	CbGpPWpGaD
Meloxicam—PGD—Metabolism—SCARB1—malaria	8.79e-05	0.00299	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	8.73e-05	0.00298	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL1B—malaria	8.69e-05	0.00296	CbGpPWpGaD
Meloxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	8.42e-05	0.00287	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TLR4—malaria	8.39e-05	0.00286	CbGpPWpGaD
Meloxicam—CYP2C9—Biological oxidations—HPGDS—malaria	8.25e-05	0.00281	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—ICAM1—malaria	8.04e-05	0.00274	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—NOS2—malaria	7.98e-05	0.00272	CbGpPWpGaD
Meloxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	7.87e-05	0.00268	CbGpPWpGaD
Meloxicam—PTGS2—C-MYB transcription factor network—CD4—malaria	7.76e-05	0.00264	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IFNG—malaria	7.74e-05	0.00264	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	7.11e-05	0.00242	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL1B—malaria	6.9e-05	0.00235	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	6.35e-05	0.00216	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—TNF—malaria	6.31e-05	0.00215	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DHODH—malaria	6.13e-05	0.00209	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IFNG—malaria	6.12e-05	0.00209	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.03e-05	0.00205	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—IL2—malaria	5.89e-05	0.00201	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	5.78e-05	0.00197	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.53e-05	0.00189	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CD36—malaria	5.51e-05	0.00188	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL1B—malaria	5.46e-05	0.00186	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—HPGDS—malaria	5.44e-05	0.00185	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL2—malaria	5.44e-05	0.00185	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CD36—malaria	5.41e-05	0.00185	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS2—malaria	5.41e-05	0.00184	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SLC4A1—malaria	5.21e-05	0.00178	CbGpPWpGaD
Meloxicam—PTGS1—Selenium Micronutrient Network—IL6—malaria	5.09e-05	0.00174	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—TNF—malaria	5.01e-05	0.00171	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DECR1—malaria	4.9e-05	0.00167	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DHODH—malaria	4.87e-05	0.00166	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.79e-05	0.00163	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS2—malaria	4.45e-05	0.00152	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HBB—malaria	4.43e-05	0.00151	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.39e-05	0.0015	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC4A1—malaria	4.14e-05	0.00141	CbGpPWpGaD
Meloxicam—PTGS2—Selenium Micronutrient Network—IL6—malaria	4.04e-05	0.00138	CbGpPWpGaD
Meloxicam—PGD—Disease—CD4—malaria	4.01e-05	0.00137	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TNF—malaria	3.96e-05	0.00135	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DHODH—malaria	3.96e-05	0.00135	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PKLR—malaria	3.95e-05	0.00135	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.89e-05	0.00133	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DECR1—malaria	3.89e-05	0.00133	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PKLR—malaria	3.74e-05	0.00128	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.57e-05	0.00122	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—G6PD—malaria	3.52e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HBB—malaria	3.52e-05	0.0012	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	3.47e-05	0.00118	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC4A1—malaria	3.37e-05	0.00115	CbGpPWpGaD
Meloxicam—PTGS2—Disease—G6PD—malaria	3.34e-05	0.00114	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DHODH—malaria	3.22e-05	0.0011	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—IL6—malaria	3.2e-05	0.00109	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.17e-05	0.00108	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DECR1—malaria	3.16e-05	0.00108	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PKLR—malaria	3.14e-05	0.00107	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—IL2—malaria	3.03e-05	0.00103	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.91e-05	0.000992	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HBB—malaria	2.86e-05	0.000975	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—G6PD—malaria	2.79e-05	0.000952	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	2.76e-05	0.00094	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC4A1—malaria	2.74e-05	0.000934	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.69e-05	0.000918	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HPGDS—malaria	2.68e-05	0.000915	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DECR1—malaria	2.58e-05	0.000878	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PKLR—malaria	2.55e-05	0.000869	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—DHFR—malaria	2.49e-05	0.000849	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—SCARB1—malaria	2.46e-05	0.00084	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DHFR—malaria	2.36e-05	0.000805	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HBB—malaria	2.33e-05	0.000794	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—G6PD—malaria	2.27e-05	0.000775	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	2.24e-05	0.000765	CbGpPWpGaD
Meloxicam—PGD—Disease—IL6—malaria	2.17e-05	0.000739	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HPGDS—malaria	2.13e-05	0.000726	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DHODH—malaria	2.12e-05	0.000724	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PKLR—malaria	2.08e-05	0.000708	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—DHFR—malaria	1.98e-05	0.000674	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SCARB1—malaria	1.96e-05	0.000667	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—G6PD—malaria	1.85e-05	0.000631	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.83e-05	0.000622	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC4A1—malaria	1.81e-05	0.000616	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HPGDS—malaria	1.73e-05	0.000591	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DECR1—malaria	1.7e-05	0.000579	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—DHFR—malaria	1.61e-05	0.000548	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SCARB1—malaria	1.59e-05	0.000543	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD36—malaria	1.55e-05	0.000527	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HBB—malaria	1.54e-05	0.000524	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HPGDS—malaria	1.41e-05	0.000481	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PKLR—malaria	1.37e-05	0.000467	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—DHFR—malaria	1.31e-05	0.000446	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SCARB1—malaria	1.3e-05	0.000442	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD36—malaria	1.23e-05	0.000418	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—G6PD—malaria	1.22e-05	0.000416	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—malaria	1.21e-05	0.000411	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD36—malaria	9.99e-06	0.000341	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HPGDS—malaria	9.31e-06	0.000317	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CD4—malaria	8.93e-06	0.000304	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—DHFR—malaria	8.63e-06	0.000294	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SCARB1—malaria	8.54e-06	0.000291	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD36—malaria	8.13e-06	0.000277	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD36—malaria	5.36e-06	0.000183	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—malaria	4.83e-06	0.000165	CbGpPWpGaD
